2018
Mechanical thrombectomy performs similarly in real world practice: a 2016 nationwide study from the Czech Republic
VOLNÝ, Ondřej, Antonin KRAJINA, Silvie BELASKOVA, Michal BAR, Petra CIMFLOVÁ et. al.Základní údaje
Originální název
Mechanical thrombectomy performs similarly in real world practice: a 2016 nationwide study from the Czech Republic
Autoři
VOLNÝ, Ondřej (203 Česká republika, garant, domácí), Antonin KRAJINA (203 Česká republika), Silvie BELASKOVA (203 Česká republika), Michal BAR (203 Česká republika), Petra CIMFLOVÁ (203 Česká republika, domácí), Roman HERZIG (203 Česká republika), Daniel SANAK (203 Česká republika), Ales TOMEK (203 Česká republika), Martin KOCHER (203 Česká republika), Miroslav ROCEK (203 Česká republika), Radek PADR (203 Česká republika), Filip CIHLAR (203 Česká republika), Miroslava NEVSIMALOVA (203 Česká republika), Lubomir JURAK (203 Česká republika), Roman HAVLICEK (203 Česká republika), Martin KOVAR (203 Česká republika), Petr SEVCIK (203 Česká republika), Vladimir ROHAN (203 Česká republika), Jan FIKSA (203 Česká republika), Bijoy K. MENON (124 Kanada) a Robert MIKULÍK (203 Česká republika, domácí)
Vydání
Journal of NeuroInterventional Surgery, London, BMJ PUBLISHING GROUP, 2018, 1759-8478
Další údaje
Jazyk
angličtina
Typ výsledku
Článek v odborném periodiku
Obor
30210 Clinical neurology
Stát vydavatele
Velká Británie a Severní Irsko
Utajení
není předmětem státního či obchodního tajemství
Impakt faktor
Impact factor: 3.925
Kód RIV
RIV/00216224:14110/18:00102128
Organizační jednotka
Lékařská fakulta
UT WoS
000442392200010
Klíčová slova anglicky
mechanical thrombectomy
Příznaky
Mezinárodní význam, Recenzováno
Změněno: 10. 2. 2019 15:52, Soňa Böhmová
Anotace
V originále
Background Randomized clinical trials have proven mechanical thrombectomy (MT) to be a highly effective and safe treatment in acute stroke. The purpose of this study was to compare neurothrombectomy data from the Czech Republic (CR) with data from the HERMES meta-analysis. Methods A vailable nationwide data for the CR from 2016 from the Safe Implementation of Treatments in Stroke-Thrombectomy (SITS-TBY) registry for patients with terminal internal carotid artery (ICA) and/or middle cerebral artery (MCA) occlusions were compared with data from HERMES. CR and HERMES patients were comparable in age, sex, and baseline National Institutes of Health Stroke Scale scores. Results From a total of 1053 MTs performed in the CR, 845 (80%) were reported in the SITS-TBY. From these, 604 (72%) were included in this study. Occlusion locations were as follows (CR vs HERMES): ICA 22% versus 21% (P=0.16), M1 MCA 62% versus 69% (P=0.004), and M2 MCA 16% versus 8% (P<0.0001). Intravenous thrombolysis was given to 76% versus 83% of patients, respectively (P=0.003). Median onset to reperfusion times were comparable: 232 versus 285 min, respectively (P=0.66). A modified Thrombolysis in Cerebral Infarction score of 2b/3 was achieved in 74% (433/584) versus 71% (390/549) of patients, respectively (OR 1.17, 95% CI 0.90-1.5, P=0.24). There was no statistically significant difference in the percentage of parenchymalhematoma type 2 (OR 1.12, 95% CI 0.66-1.90, P=0.68). A modified Rankin Scale score of 0-2 at 3 months was achieved in 48% (184/268) versus 46% (291/633) of patients, respectively (OR 0.92, 95% CI 0.71-1.18, P=0.48).